NPI: 1467408781 · WINCHESTER, TN 37398 · General Acute Care Hospital · NPI assigned 05/26/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 05/26/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,646 | $1.47M |
| 2019 | 23,607 | $1.31M |
| 2020 | 22,319 | $979K |
| 2021 | 32,761 | $1.34M |
| 2022 | 37,906 | $1.58M |
| 2023 | 40,407 | $1.55M |
| 2024 | 21,287 | $1.17M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 29,789 | 25,792 | $4.27M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 24,947 | 22,152 | $3.06M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 6,872 | 2,893 | $311K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,285 | 1,106 | $285K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,703 | 4,011 | $209K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,244 | 984 | $178K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4,688 | 4,220 | $162K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,612 | 3,291 | $121K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 25,099 | 20,508 | $106K |
| 80053 | Comprehensive metabolic panel | 22,244 | 18,360 | $70K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4,833 | 4,276 | $47K |
| 97597 | 2,520 | 1,203 | $42K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,847 | 1,641 | $42K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,240 | 297 | $37K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 713 | 653 | $36K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,860 | 1,747 | $34K |
| 84484 | 3,856 | 2,929 | $34K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,860 | 1,438 | $19K |
| 83735 | 5,369 | 4,274 | $18K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,815 | 1,553 | $18K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 897 | 729 | $17K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 16 | 14 | $16K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,017 | 3,875 | $15K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,564 | 1,342 | $15K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 527 | 499 | $14K |
| 64493 | 60 | 39 | $12K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,023 | 1,730 | $12K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 534 | 380 | $11K |
| 71045 | Radiologic examination, chest; single view | 4,710 | 3,847 | $10K |
| 87430 | 1,055 | 1,011 | $9K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 69 | 54 | $8K |
| 83690 | 1,822 | 1,519 | $7K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 74 | 65 | $7K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 177 | 155 | $7K |
| 83605 | 1,055 | 831 | $7K | |
| 87070 | 921 | 873 | $6K | |
| 70450 | Computed tomography, head or brain; without contrast material | 229 | 183 | $6K |
| 93017 | 113 | 87 | $6K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 15 | 13 | $5K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 123 | 92 | $5K |
| 87486 | 108 | 105 | $5K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 108 | 105 | $5K |
| 81001 | 6,218 | 5,258 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | 768 | 706 | $5K |
| 36415 | Collection of venous blood by venipuncture | 1,432 | 1,250 | $4K |
| 81025 | 1,244 | 1,149 | $4K | |
| J2785 | Injection, regadenoson, 0.1 mg | 39 | 37 | $4K |
| 82150 | 984 | 820 | $4K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 31 | 24 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 565 | 483 | $3K |
| 83880 | 581 | 442 | $3K | |
| 64494 | 59 | 39 | $3K | |
| 78414 | 70 | 54 | $3K | |
| 85730 | 1,121 | 889 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 39 | 37 | $3K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 70 | 54 | $3K |
| 93226 | 41 | 36 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 859 | 777 | $2K |
| G0378 | Hospital observation service, per hour | 17 | 12 | $2K |
| 82550 | 646 | 505 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 45 | 37 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | 284 | 240 | $2K |
| 85610 | 1,189 | 939 | $2K | |
| 86141 | 465 | 354 | $2K | |
| 87581 | 43 | 42 | $2K | |
| 81003 | 2,033 | 1,820 | $1K | |
| 87634 | 39 | 38 | $1K | |
| 11045 | 63 | 12 | $1K | |
| 93225 | 118 | 94 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 616 | 485 | $1K |
| 76801 | 17 | 15 | $1K | |
| 80061 | Lipid panel | 170 | 129 | $886.02 |
| 74018 | 35 | 26 | $714.97 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 46 | 44 | $604.17 |
| 94060 | 14 | 14 | $536.64 | |
| 87400 | 106 | 96 | $519.11 | |
| 84100 | 304 | 242 | $375.73 | |
| 87799 | 14 | 14 | $365.86 | |
| 82247 | 67 | 41 | $338.36 | |
| 87040 | 43 | 27 | $282.77 | |
| 82570 | 95 | 88 | $280.06 | |
| 94727 | 14 | 14 | $258.64 | |
| 94729 | 14 | 14 | $221.49 | |
| 85378 | 17 | 15 | $146.45 | |
| 83970 | 43 | 39 | $145.20 | |
| 80305 | 32 | 26 | $118.37 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 75 | 64 | $116.72 |
| 87205 | 51 | 43 | $64.14 | |
| 88304 | 46 | 44 | $43.27 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 306 | 255 | $38.83 |
| 72110 | 18 | 12 | $33.59 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 861 | 758 | $30.26 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,065 | 796 | $19.86 |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,297 | 2,093 | $2.24 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,783 | 1,645 | $1.32 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 402 | 339 | $1.26 |
| 85651 | 29 | 26 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 456 | 376 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 13 | 12 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 26 | 25 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 32 | 24 | $0.00 |
| 84134 | 28 | 24 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 15 | 12 | $0.00 |
| 87077 | 44 | 37 | $0.00 | |
| 87075 | 51 | 43 | $0.00 | |
| 87186 | 12 | 12 | $0.00 |